EM-T3Expert Opinion on Drug Safety2018-11-18第 17 卷第 12 期，1153-1153通讯与评论开放获取
Reply to Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis
